
KYMERA THERAPEUTICS INC
KYMR · NASDAQ
Updated at 2026-10-14 11:07:53
- Today's High
- $112.06
- Today’s Low
- $106.52
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $111.61
- Previous Close
- $112.08
- Volume
- 537.52K
- Market Cap
- $9.31B
- P/E Ratio
- --
- EPS
- $-3.24
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Biotechnology
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- 500 NORTH BEACON STREET, WATERTOWN, MA, UNITED STATES, 02472
- Country
- US
- Listing Date
- 2020-08-21
- Fiscal Year End
- December
- Shares Outstanding
- 82.26M
- CIK
- 0001815442
- Website
- www.kymeratx.com
Kymera Therapeutics, Inc., a biopharmaceutical company, is focused on discovering and developing new small molecule treatments that selectively break down disease-causing proteins by harnessing the body's own natural protein breakdown system. The company is headquartered in Watertown, Massachusetts.
Financial Metrics
--
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.